DC Field | Value | Language |
dc.contributor.author | Vlasov, Lilia | |
dc.date.accessioned | 2020-05-09T17:21:29Z | |
dc.date.available | 2020-05-09T17:21:29Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | VLASOV, L. Evidenţierea aspectelor fiziopatologice ale sindromului hepato-renal la pacienţii cu ciroză hepatică. In: Arta Medica. 2011, nr. 2(45), pp. 285-287. ISSN 1810-1852. | en_US |
dc.identifier.issn | 1810-1852 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/9292 | |
dc.description | Catedra de Medicină Internă Nr.5 USMF ,,N. Testemiţanu”, Secţia Nefrologie şi Hemodializă IMSP SCM ”Sfânta Treime”, Al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională (1-13 iunie 2011) | en_US |
dc.description.abstract | Summary. Hepato-renal syndrome is caused by renal vasoconstriction and impaired glomerular perfusion, both of which may be mediated by increased formation of vasoactive mediators such as endotelin-1 and decreased plasma prostaglandin E-2 production. The plasma endothelin (ET) and PGE-2 levels were evaluated in 114 patients with hepatic cirrhosis, including 23 patients with hepato-renal syndrome. The determination of ET-1, PGE-2 and urinary enzymes can be included in the prognostic assessment of patient with decompensate cirrhosis and hepato-renal syndrome. | en_US |
dc.language.iso | ro | en_US |
dc.publisher | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova | en_US |
dc.subject.mesh | Liver cirrhosis - physiopathology | en_US |
dc.subject.mesh | Hepatorenal syndrome - physiopathology | en_US |
dc.subject.mesh | Liver cirrhosis--diagnosis | en_US |
dc.title | Evidenţierea aspectelor fiziopatologice ale sindromului hepato-renal la pacienţii cu ciroză hepatică | en_US |
dc.title.alternative | Pathways of pathophysiologic mechanisms in patients with hepatic cirrhosis and hepato-renal syndrome | en_US |
dc.type | Article | en_US |
Appears in Collections: | Arta Medica Vol. 45 No.2, 2011 ediţie specială
|